Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Synaptogenix
(NASDAQ:SNPX)
Intraday
$4.40
-0.16
[-3.51%]
After-Hours
$4.40
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$4.40
-0.16
[-3.51%]
At close: Apr 24
$4.40
0
[0.00%]
After Hours: 7:25AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Synaptogenix Stock (NASDAQ:SNPX)
Synaptogenix Stock (NASDAQ: SNPX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Synaptogenix Regains Compliance With Nasdaq Minimum Bid Price Requirement For Continued Listing
Benzinga Newsdesk
-
1 day ago
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 10, 2024, 8:09AM
Tuesday, April 09, 2024
Synaptogenix Acquires 25% Stake In Cannasoul
Benzinga Newsdesk
-
Apr 9, 2024, 9:18AM
Thursday, April 04, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Apr 4, 2024, 7:50PM
What's Going On With Synaptogenix (SNPX) Stock?
Henry Khederian
-
Apr 4, 2024, 11:49AM
Wednesday, April 03, 2024
Synaptogenix shares are trading lower. The company announced a 1-for-25 reverse stock split.
Benzinga Newsdesk
-
Apr 3, 2024, 11:07AM
Synaptogenix Announces 1-for-25 Reverse Stock Split To Maintain Nasdaq Listing
Benzinga Newsdesk
-
Apr 3, 2024, 8:17AM
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Mar 14, 2024, 5:33PM
Thursday, February 22, 2024
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 22, 2024, 1:37PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Feb 22, 2024, 12:31PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 22, 2024, 8:05AM
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 22, 2024, 7:55AM
Wednesday, February 21, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 21, 2024, 4:31PM
Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"
Benzinga Newsdesk
-
Feb 21, 2024, 3:58PM
Wednesday, January 31, 2024
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 31, 2024, 1:18PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 31, 2024, 12:31PM
Why Sintx Technologies Shares Are Trading Higher By Over 39%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 31, 2024, 8:17AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 31, 2024, 8:05AM
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 22, 2024, 12:31PM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 15, 2024, 4:30PM
Monday, January 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 8, 2024, 4:31PM
Friday, January 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Jan 5, 2024, 4:30PM
Tuesday, December 26, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Dec 26, 2023, 4:31PM
Wednesday, December 06, 2023
Synaptogenix Joins Neuroscientists And Academics As Speaker At USC-Sponsored Forum On Age-Related Diseases Including Alzheimer's
Benzinga Newsdesk
-
Dec 6, 2023, 9:01AM
Thursday, November 02, 2023
Cutting-Edge Cannabis Products On The Horizon As Biotech Co. Funds New Research
Jelena Martinovic
-
Nov 2, 2023, 1:21PM
Wednesday, October 18, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 18, 2023, 9:06AM
Tuesday, September 26, 2023
Synaptogenix Announces Peer-Reviewed Publication Of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, And Persistent Benefits Of Bryostatin-1 in Advanced Alzheimer's Disease
Benzinga Newsdesk
-
Sep 26, 2023, 9:17AM
Friday, September 22, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Sep 22, 2023, 5:31PM
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 22, 2023, 2:22PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Sep 22, 2023, 1:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Sep 22, 2023, 9:06AM
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 11, 2023, 1:38PM
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 8, 2023, 1:58PM
Thursday, September 07, 2023
Synaptogenix Says Bryostatin-1 Shows Statistically Significant Results As An ALS Treatment In Pre-Clinical Independent Study
Benzinga Newsdesk
-
Sep 7, 2023, 9:06AM
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 5, 2023, 1:34PM
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 22, 2023, 1:51PM
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 14, 2023, 1:48PM
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 9, 2023, 12:27PM
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 8, 2023, 1:32PM
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 7, 2023, 12:13PM
Friday, August 04, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Aug 4, 2023, 2:06PM
Thursday, August 03, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Aug 3, 2023, 2:45PM
Wednesday, August 02, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 2, 2023, 1:55PM
Wednesday, July 19, 2023
Synaptogenix And Cleveland Clinic To Submit Investigational New Drug Application To FDA For Clinical Trial Of Bryostatin-1 In Multiple Sclerosis
Benzinga Newsdesk
-
Jul 19, 2023, 9:02AM
Friday, July 14, 2023
Short Volatility Alert: Synaptogenix Inc
Christopher Sappo
-
Jul 14, 2023, 10:21AM
Thursday, July 13, 2023
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Jul 13, 2023, 12:49PM
Nasdaq Rises Over 100 Points; Delta Air Lines Posts Upbeat Results
Lisa Levin
-
Jul 13, 2023, 12:21PM
Synaptogenix shares are trading higher after the company announced an abstract featuring secondary endpoint data of its NIH-sponsored Phase 2 Bryostatin-1 trial was accepted for presentation at the 11th IBRO World Congress of Neuroscience.
Benzinga Newsdesk
-
Jul 13, 2023, 11:19AM
Dow Gains Over 100 Points; US Producer Prices Rise 0.1% In June
Lisa Levin
-
Jul 13, 2023, 10:30AM
Synaptogenix Shares Resume Trade Following Circuit Breaker Halt
Happy Mohamed
-
Jul 13, 2023, 10:18AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch